Pharmabiz1d
Vera Therapeutics completes full enrollment in pivotal ORIGIN phase 3 trial for Atacicept in patients with IgA nephropathy
Brisbane, California Saturday, April 5, 2025, 15:00 Hrs [IST] ...
Pharmabiz1d
Intellia Therapeutics doses first patient in MAGNITUDE-2 phase 3 study of nexiguran ziclumeran
Intellia Therapeutics doses first patient in MAGNITUDE-2 phase 3 study of nexiguran ziclumeran: Cambridge, Massachusetts Saturday, April 5, 2025, 18:00 Hrs [IST] Intellia Therapeu ...
Pharmabiz1d
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...
Pharmabiz2d
Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi
Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi: Our Bureau, Mumbai Friday, April 4, ...
Pharmabiz1d
EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer
EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...
Pharmabiz1d
US FDA approves Amgen’s Uplizna to treat IgG4-related disease
US FDA approves Amgen’s Uplizna to treat IgG4-related disease: Thousand Oaks, California Saturday, April 5, 2025, 11:00 Hrs [IST] Amgen announced that the US Food and Drug Admin ...
Pharmabiz1d
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD: Our Bureau, New Delhi Saturday, ...
Pharmabiz1d
Clinical Trials Information System designated as WHO primary registry
The Clinical Trials Information System (CTIS) has been designated as a primary registry by the World Health Organisation (WHO) within the International Clinical Trials Registry Platform (ICTRP).
Pharmabiz2d
Abbott introduces next-generation delivery system to streamline electrode placement during dorsal root ganglion stimulator implantations
Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...
Pharmabiz2d
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources
Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources: Dublin, Ireland Friday, April 4, 2025, 18:00 Hrs [IST] Biologit, a spec ...
Pharmabiz1d
Indian healthcare sees urgent need for skill development to offset shortfall of doctors, nurses and paramedics
Nandita Vijayasimha, Bengaluru Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz2d
Helsinn Group submits new innovative formulation of Akynzeo to European Medicines Agency
Helsinn Group submits new innovative formulation of Akynzeo to European Medicines Agency: Lugano, Switzerland Friday, April 4, 2025, 17:00 Hrs [IST] Helsinn Group, a global pharma ...